The Competition Council has fined pharmaceutical company Boehringer Ingelheim RCV Gmbh & Co KG (Austria) with 128.470 million RON (25.81 million euros) for abuse of a dominant position on the Romanian market of medicines intended for the treatment of chronic obstructive pulmonary disease (COPD), according to a press release.The competition authority found that, over 2017-2021, Boehringer Ingelheim RCV Gmbh & Co KG limited market access to the generic medicine Spiriva (cheaper) and directed patients to Spiolto Respimat, an innovative, more complex and more expensive medicine.According to the Therapeutic Guide in force at that time and the national protocol, not all patients affected by COPD have a more complex medicine as their first treatment option (dual therapy), some of them having the medicine Spiriva and implicitly its generic versions (monotherapy) as their initial indication.Boehringer Ingelheim RCV Gmbh & Co KG has carried out an intensive communication and promotion strategy to influence doctors' decisions so that they will prescribe the drug Spiolto Respimat more widely.In this way, the company intended to make it more difficult to sell competing generic drugs similar to Spiriva and to direct the revenues generated by this product to the new drug Spiolto Respimat.Both drugs are reimbursed 50% by the Health Insurance House, the difference being paid by patients.The clues that were the basis for triggering the investigation also included information received on the Competition Whistleblower Platform, a tool through which violations of the Competition Law can be brought to the attention of the authority, anonymously. The platform can be accessed at https://report.whistleb.com/ro/consiliulconcurentei.
The second stage of the international Grand Chess Tour, one of the most important chess tournaments in the world, will take place in Bucharest from May 7 to May 16. The first stage of will take place in Warsaw, Poland. However, the event’s opening will take place on May 6. In addition to these two, […]
Voxxed Days Bucharest 2025 concluded the 2025 edition on 27th March, after two days of successful workshops and conferences. "I'm grateful we managed to bring together 300 developers and tech team leaders again this year, in a conference dedicated to a passionate developer community. It was a significantly bigger effort than in previous years, given […]
Romania’s civil shelters, which are to be used to protect people in the event of armed conflict, are few, unsanitary, and largely obsolete in terms of equipment, according to a report by the Court of Accounts. The audit conducted by the Court of Accounts on the situation of civil...
The organizers of music festivals Untold and Neversea have signed an agreement with the Bucharest City Hall to organize a "mega-festival" in the capital this year. The large-scale project is set for a pilot edition this year, with plans to have it "grow year by year." It will take place at Arena Naţională. The talks […]
Around 61% of Romanians say they have been the target of online fraud attempts, the most common consequences being the infection of the device with malware or viruses (42%) and the loss of money (30%), according to the latest study conducted by Reveal Marketing Research. Of those who have been targeted, 39% have experienced such […]
Showpad, active in AI-driven revenue enablement technology, announced the official launch of its Research and Development center in Bucharest. With headquarters in Ghent (Belgium) and Chicago (US), Showpad is "strategically positioning its new R&D center to tap into the rich talent pool and burgeoning technology ecosystem of Romania." It also underscores Showpad's dedication to accelerating […]
